ARCHIVES

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

This article is from The Cancer Letter archive.

Vol. 31 No. 01 | January 7, 2005

Download PDF Visit The Full Archive

Related Articles

Nominations Open for Bristol-Myers $25,000

September 29, 1978

Capitol Hill: Bills Seeks Coverage for Treatment Of cancers Found in CDC Screening

April 2, 1999

NTP Board Plans Peer Review Of Bioassay Reports

April 11, 1980

Senate Committee Adds $200 Mil. To NCI Request For FY92; Centers, Women’s Health, Targeted

July 19, 1991

Women PIs Score Highest In RFA To Encourage Early Breast Cancer Detection

May 1, 1987

“The President Has Cancer”: NCI Surgery Chief Breaks The News To Reagans And The World as Chief Spokesman After Surgery

July 19, 1985